chr22-28695865-ATC-TTA

Variant summary

Our verdict is Pathogenic.
+10 Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 10 classification points (ACMG Germline Pathogenicity v2019). PVS1PM2

The NM_007194.4(CHEK2):c.1102_1104delinsTAA (p.Asp368Ter) variant causes a stop gained change. The variant is predicted to lead to nonsense-mediated mRNA decay (NMD). Note: allele frequency estimates from gnomAD may be inaccurate for this variant type (MNP or indel longer than 3 bp) due to technology limitations. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 32)

Consequence

CHEK2
NM_007194.4 stop_gained

Predictors

Not classified

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 6.94

Publications

0 publications found
Genes affected
CHEK2 (HGNC:16627): (checkpoint kinase 2) In response to DNA damage and replication blocks, cell cycle progression is halted through the control of critical cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint regulator and putative tumor suppressor. It contains a forkhead-associated protein interaction domain essential for activation in response to DNA damage and is rapidly phosphorylated in response to replication blocks and DNA damage. When activated, the encoded protein is known to inhibit CDC25C phosphatase, preventing entry into mitosis, and has been shown to stabilize the tumor suppressor protein p53, leading to cell cycle arrest in G1. In addition, this protein interacts with and phosphorylates BRCA1, allowing BRCA1 to restore survival after DNA damage. Mutations in this gene have been linked with Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in TP53. Also, mutations in this gene are thought to confer a predisposition to sarcomas, breast cancer, and brain tumors. This nuclear protein is a member of the CDS1 subfamily of serine/threonine protein kinases. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
CHEK2 Gene-Disease associations (from GenCC):
  • CHEK2-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics, ClinGen
  • Li-Fraumeni syndrome 2
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • hereditary breast carcinoma
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • acute myeloid leukemia
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary nonpolyposis colon cancer
    Inheritance: Unknown Classification: LIMITED Submitted by: ClinGen
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_007194.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Pathogenic. The variant received 10 points.

PVS1Null variant in LOF gene
Frameshift/stop-gained, NMD predicted, LoF disease mechanism — very strong (PVS1); Stop-gained (exon 11 of 15) at amino acid 368 of 543, predicted to trigger nonsense-mediated mRNA decay. Loss of function is a known disease mechanism for this gene.
PM2Absent/extremely low in population databases
Absent from gnomAD (AD/XL gene) — PM2; Absent from gnomAD at well-covered site (MOI: AD+AR) (base 0.0001, raised to 0.0005 by highest known P/LP ClinVar AF 0.00276) — PM2 moderate.

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_007194.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

CHEK2 NM_007194.4
MANE Select
HGVSc / HGVSpc.1102_1104delinsTAAp.Asp368Ter
Exon rankExon 11 of 15
stop_gained
Prot: NP_009125.1
CHEK2 NM_001005735.3
HGVSc / HGVSpc.1231_1233delinsTAAp.Asp411Ter
Exon rankExon 12 of 16
stop_gained
Prot: NP_001005735.1
CHEK2 NM_001438293.1
HGVSc / HGVSpc.1195_1197delinsTAAp.Asp399Ter
Exon rankExon 12 of 16
stop_gained
Prot: NP_001425222.1

Ensembl Transcripts

CHEK2 ENST00000404276.6
MANE Select
HGVSc / HGVSpc.1102_1104delinsTAAp.Asp368Ter
Exon rankExon 11 of 15
stop_gained
Prot: ENSP00000385747
CHEK2 ENST00000382580.7
TSL:1
HGVSc / HGVSpc.1231_1233delinsTAAp.Asp411Ter
Exon rankExon 12 of 16
stop_gained
Prot: ENSP00000372023
CHEK2 ENST00000403642.5
TSL:1
HGVSc / HGVSpc.829_831delinsTAAp.Asp277Ter
Exon rankExon 8 of 12
stop_gained
Prot: ENSP00000384919

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 2 sources
GnomAD3 genomes
Cov:32
GnomAD4 genome
Cov:32
Showing 2 sources

ClinVar

Not reported in ClinVar

Computational Scores

PhyloP100
Uncertain6.9
Showing 1 of 1 scores

Splicing Scores

No splicing scores have been computed for this variant.

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

1 abnormal (RUO)
Protein level
CHEK2 Yeast Complementation in MMS
CHEK2 Yeast Complementation
Gene
CHEK2
Assay type
Cell fitness
Mechanism
DNA damage checkpoint signaling
Model system
Yeast (Saccharomyces cerevisiae)
Score
-2.06 · p.Asp368Ter (assay numbering)
Classified as
No clinical calibration. Only research-use-only (RUO) calibrations exist for this assay — they are not reliable evidence; treat them with extreme caution.
PS3 moderateFunctionally abnormalRUO
ExCALIBR calibration: PS3 Moderate (2)

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.